O'Bryant CL - Search Results

1

Board-Certified Oncology Pharmacists: Their Potential Contribution to Reducing a Shortfall in Oncology Patient Visits.

Ignoffo R, Knapp K, Barnett M, Barbour SY, D'Amato S, Iacovelli L, Knudsen J, Koontz SE, Mancini R, McBride A, McCauley D, Medina P, O'Bryant CL, Scarpace S, Stricker S, Trovato JA. Ignoffo R, et al. J Oncol Pract. 2016 Apr;12(4):e359-68. doi: 10.1200/JOP.2015.008490. Epub 2016 Mar 22. J Oncol Pract. 2016. PMID: 27006358

2

Implementation of a pharmacist-managed clinic for patients with chronic nonmalignant pain.

Norman JL, Kroehl ME, Lam HM, Lewis CL, Mitchell CN, O'Bryant CL, Trinkley KE. Norman JL, et al. Am J Health Syst Pharm. 2017 Aug 15;74(16):1229-1235. doi: 10.2146/ajhp160294. Am J Health Syst Pharm. 2017. PMID: 28790075

3

Evaluation of fosaprepitant-associated hypersensitivity reactions at a National Cancer Center.

Laird CM, Glode AE, Schwarz K, Lam ET, O'Bryant CL. Laird CM, et al. Among authors: o bryant cl. J Oncol Pharm Pract. 2020 Sep;26(6):1369-1373. doi: 10.1177/1078155219895312. Epub 2020 Jan 19. J Oncol Pharm Pract. 2020. PMID: 31955703

4

Claims analysis of hypertension occurrence, severity changes and patterns of antihypertensive use in cancer patients receiving vascular endothelial growth factor inhibitors.

Thompson LA, Saseen JJ, O'Bryant CL, Allen RR, Nair KV. Thompson LA, et al. J Oncol Pharm Pract. 2015 Aug;21(4):258-67. doi: 10.1177/1078155214530177. Epub 2014 Apr 11. J Oncol Pharm Pract. 2015. PMID: 24727344

5

Screening and management of osteoporosis in breast cancer patients on aromatase inhibitors.

Gibson K, O'Bryant CL. Gibson K, et al. J Oncol Pharm Pract. 2008 Sep;14(3):139-45. doi: 10.1177/1078155208091866. J Oncol Pharm Pract. 2008. PMID: 18719068

6

The need for PGY2-trained clinical pharmacy specialists.

Ragucci KR, O'Bryant CL, Campbell KB, Buck ML, Dager WE, Donovan JL, Emerson K, Gubbins PO, Haight RJ, Jackevicius C, Murphy JE, Prohaska E. Ragucci KR, et al. Pharmacotherapy. 2014 Jun;34(6):e65-73. doi: 10.1002/phar.1430. Epub 2014 Apr 18. Pharmacotherapy. 2014. PMID: 24752824

7

Hematology/Oncology Pharmacy Association Entry-level Competencies Task Force Response Statement to the 2016 American College of Clinical Pharmacy Pharmacotherapy Didactic Curriculum Toolkit.

Nightingale G, Saunders IM, Comeau JM, Fancher K, Miller T, O'Bryant C, Yeh J; Hematology/Oncology Pharmacy Association Entry-level Competencies Task Force. Nightingale G, et al. Pharmacotherapy. 2017 May;37(5):e30-e31. doi: 10.1002/phar.1919. Epub 2017 Apr 7. Pharmacotherapy. 2017. PMID: 28247517 No abstract available.

8

Community pharmacists' knowledge of and attitudes toward oral chemotherapy.

O'Bryant CL, Crandell BC. O'Bryant CL, et al. J Am Pharm Assoc (2003). 2008 Sep-Oct;48(5):632-9. doi: 10.1331/JAPhA.2008.07082. J Am Pharm Assoc (2003). 2008. PMID: 18826902

9

Antibody-Drug Conjugates: A Clinical Pharmacy Perspective on an Emerging Cancer Therapy.

Jerjian TV, Glode AE, Thompson LA, O'Bryant CL. Jerjian TV, et al. Pharmacotherapy. 2016 Jan;36(1):99-116. doi: 10.1002/phar.1687. Pharmacotherapy. 2016. PMID: 26799352 Review.

10

A phase I study of gefitinib, capecitabine, and celecoxib in patients with advanced solid tumors.

Lam ET, O'Bryant CL, Basche M, Gustafson DL, Serkova N, Baron A, Holden SN, Dancey J, Eckhardt SG, Gore L. Lam ET, et al. Mol Cancer Ther. 2008 Dec;7(12):3685-94. doi: 10.1158/1535-7163.MCT-08-0436. Mol Cancer Ther. 2008. PMID: 19074845 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters